We have updated our Terms of Use.
Please read our new Privacy Statement before continuing.

Season of goodwill

2 January 2004 By Robert Cyran

Proposed US rules make tech and biotech mergers less appealing after December 2004. Acquired R&D can no longer be written down so acquisitive companies will report lower earnings and returns on equity.

This content is for Subscribers only


Email a friend

Please complete the form below.

Required fields *


(Separate multiple email addresses with commas)